News

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and

Swarmer (NASDAQ:SWMR) reported a sharp year-over-year decline in first-quarter revenue in its first earnings call as a public company, while management emphasized that the company is investing in

Brainsway (NASDAQ:BWAY) reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its

• MarketBeat Week in Review – 11/4 - 11/8

Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic

• Big Insider Sales at NVDA, DELL, TMUS Raise Questions—Or Do They?

Deutsche Telekom (ETR:DTE) reported what Chief Executive Tim Höttges called a “robust” start to 2026, citing broad-based growth

Deutsche Börse (ETR:DB1) used its annual general meeting to highlight another record year, outline its “Leading the Transformation” strategy and address shareholder questions on capital returns

• Bridget’s Buys: The Bottom 5 Stocks and What to Do Next

Oklo (NYSE:OKLO) reported a wider first-quarter 2026 loss as the advanced nuclear developer said it is moving further into asset deployment

• 3 high yield stock ETFs that make any income portfolio better

Nu Skin Enterprises (NYSE:NUS) reported first-quarter 2026 results that management said were in line with expectations, as the company

• 3 lithium stocks at rock bottom prices for EV believers

Lithium Americas (Argentina) (NYSE:LAAC) reported a stronger first quarter for 2026, with Chief Executive Officer Sam Pigott saying the

• This Underrated Natural Gas Stock Could Rally Double-Digits Soon

Natural Gas Services Group (NYSE:NGS) reported a record first quarter, with management citing higher utilization, large-horsepower

• 3 Stocks Poised to Grow on European Rearmament Spending

Karman (NYSE:KRMN) reported record fiscal first-quarter results and raised its full-year outlook, citing broad-based growth across its legacy

OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life

Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and

• 3 Penny Stocks Analysts Believe Are Headed Higher

Intellicheck Mobilisa (NASDAQ:IDN) reported higher first-quarter revenue and profitability, with management saying growth in banking and lending

• Are These 3 Under-the-Radar AI Stocks the Next Big Growth Stories?

Audioeye (NASDAQ:AEYE) reported first-quarter 2026 revenue growth and raised its profitability outlook, while outlining a

• Bargain Alert on 3 Stocks Investors Have Oversold

Amentum (NYSE:AMTM) reported what executives described as solid second-quarter fiscal 2026 results, supported by growth in key markets, strong

Veritone (NASDAQ:VERI) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, citing growing demand for its AI training data services, public sector software and recently

Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and